Analystreport

Orchard Therapeutics PLC - (NASDAQ: ORTX) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $26.00 to $16.00. They now have an "outperform" rating on the stock.

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report